Anastomosis Devices Market Summary

The global anastomosis devices market was valued at USD 4.19 billion in 2024 and is projected to reach USD 5.80 billion by 2030, growing at a CAGR of 5.6% from 2025 to 2030. This growth reflects the increasing reliance on advanced surgical tools to improve patient outcomes and reduce post-operative complications. An estimated 310 million major surgeries are performed annually worldwide, with the U.S. accounting for approximately 40 to 50 million of these operations, highlighting the significant and consistent demand for surgical devices, including anastomosis solutions, across healthcare systems.

This escalation is largely propelled by the rapidly aging global population and the rising prevalence of lifestyle-related diseases, particularly cardiovascular conditions and cancer. These chronic conditions often require complex surgical interventions where safe and efficient tissue or vessel connection is critical. As surgical intervention becomes a standard necessity in addressing these health challenges, the demand for effective anastomosis devices has escalated. Technological advancements that improve precision, reduce surgery time, and enhance healing outcomes are further contributing to increased adoption, indicating a market poised for sustained and substantial expansion.

Key Market Trends & Insights

• The North America region held the largest market share, accounting for 40.2% of the total market revenue in 2024, supported by advanced healthcare infrastructure, high surgical volumes, and early adoption of innovative medical devices.
• The Asia Pacific region is identified as the fastest-growing market, with a CAGR of 6.9% over the forecast period, driven by expanding healthcare access, growing medical tourism, rising patient populations, and increasing investments in healthcare infrastructure across emerging economies.
• By product, the disposable products segment contributed to the largest share of around 88.5% of the global market revenue in 2024, due to their convenience, reduced risk of infection, and compliance with strict hygiene standards.
• By application, cardiovascular surgery led the market and accounted for a share of 51.0% in 2024, reflecting the high incidence of heart-related conditions requiring surgical treatment.
• By end use, hospitals held the largest revenue share of 57.5% in 2024, as they serve as primary centers for major and complex surgical procedures.

Order a free sample PDF of the Anastomosis Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 4.19 Billion
• 2030 Projected Market Size: USD 5.80 Billion
• CAGR (2025-2030): 5.6%
• North America: Largest Market in 2024

Key Companies & Market Share Insights

Some key companies operating in the market include Medtronic; MIZUHO Corporation; Getinge; Peters Surgical; and Baxter; among others. Key players operating in the market are focusing on technological innovations and developing advanced technology-based devices to gain a significant revenue share. Companies are focusing on Gripping Surface Technology (GST), magnetic anastomosis technology, and 3D stapling technology for developing anastomosis devices that can reduce leaks at the staple line and provide less invasive solutions for surgeons & patients.

• MIZUHO Corporation specializes in advanced surgical instruments and medical devices tailored for anastomosis procedures. Their portfolio includes specialized clamps and suturing devices that enhance surgical precision and improve patient outcomes during complex cardiovascular surgeries.
• Peters Surgical emphasizes innovative surgical solutions, notably their Enclose® II Proximal Anastomosis Assist Device, designed for anastomosis during beating heart surgeries. Their products enhance efficiency and safety in surgical procedures, providing comprehensive solutions for diverse anastomotic techniques.

Key Players

• Medtronic
• MIZUHO Corporation
• Getinge
• Peters Surgical
• Baxter
• Medical Device Business Services, Inc.
• CarpoNovum AB
• Vascular Graft Solutions Ltd.
• Medline Industries, LP.
• Seger Surgical Solutions Ltd.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The anastomosis devices market is steadily expanding due to rising surgical volumes, aging populations, and increasing prevalence of chronic diseases such as cardiovascular disorders and cancer. Technological advancements and preference for disposable products are enhancing surgical efficiency and patient safety. North America continues to dominate the market, while Asia Pacific shows strong growth potential driven by healthcare expansion. Hospitals remain the primary end users, particularly for cardiovascular applications. Overall, the market is expected to maintain consistent growth, supported by innovation, increasing healthcare investments, and growing global demand for advanced surgical solutions.